| __timestamp | Intra-Cellular Therapies, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 242549000 |
| Thursday, January 1, 2015 | 87718074 | 245098000 |
| Friday, January 1, 2016 | 93831530 | 147600000 |
| Sunday, January 1, 2017 | 79419009 | 264600000 |
| Monday, January 1, 2018 | 132166913 | 357900000 |
| Tuesday, January 1, 2019 | 89124838 | 1182600000 |
| Wednesday, January 1, 2020 | 65782137 | 357700000 |
| Friday, January 1, 2021 | 88845513 | 540100000 |
| Saturday, January 1, 2022 | 134715000 | 322900000 |
| Sunday, January 1, 2023 | 180142000 | 408000000 |
Unlocking the unknown
In the ever-evolving world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, United Therapeutics Corporation and Intra-Cellular Therapies, Inc. have demonstrated distinct strategies in their R&D allocations.
From 2014 to 2023, United Therapeutics consistently invested heavily in R&D, with expenditures peaking in 2019, reflecting a strategic push towards groundbreaking therapies. Their R&D spending in 2023 was approximately 70% higher than in 2014, showcasing a robust growth trajectory.
In contrast, Intra-Cellular Therapies, Inc. exhibited a more fluctuating pattern, with a notable surge in 2023, marking an 85% increase from their 2014 levels. This suggests a strategic pivot towards expanding their research capabilities.
These trends highlight the dynamic nature of R&D investments in the biotech sector, where strategic financial decisions can pave the way for future innovations.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
United Therapeutics Corporation or Sarepta Therapeutics, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Halozyme Therapeutics, Inc.
United Therapeutics Corporation or Grifols, S.A.: Who Invests More in Innovation?
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: United Therapeutics Corporation and Ultragenyx Pharmaceutical Inc.
Research and Development Investment: United Therapeutics Corporation vs Corcept Therapeutics Incorporated
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Madrigal Pharmaceuticals, Inc.
Intra-Cellular Therapies, Inc. or Mesoblast Limited: Who Invests More in Innovation?